- Qualio is a leading AI-powered compliance platform for life sciences, specializing in quality management and regulatory compliance for medical devices and pharmaceuticals, helping organizations streamline their processes and achieve audit readiness.
- In the past year, Qualio raised $50 million in a Series B funding round to enhance its platform capabilities, including the launch of Compliance Intelligence, which automates gap analysis and continuous monitoring for regulatory compliance.
- The company serves over 10,000 public and private organizations, providing solutions that have demonstrated a 80% reduction in audit preparation time and a 5x ROI in just two months, making it a vital partner for businesses in the life sciences sector.
- Qualio's ideal buyers are compliance and quality assurance leaders in life sciences companies who face challenges with regulatory compliance and audit readiness, making their platform essential for accelerating product development and market entry.
Qualio's workforce is organized across 12 departments, with the largest being Information Technology at 27 employees, followed by Sales with 21. Community and Social Services, Executive, and Marketing each contribute 9 employees, indicating a balanced focus on both technical and client-facing functions. The distribution across departments reflects a strategic alignment with the company's operational goals, ensuring adequate support for both development and customer engagement.
The company operates across 17 locations, with the largest concentration in San Francisco, CA, housing 23 employees. Other notable locations include New York, NY, and Atlanta, GA, each with 2 employees. The designation of 'Other' accounts for a significant portion of the workforce, indicating a distributed model that likely supports remote work arrangements. This geographic distribution suggests a flexible approach to talent acquisition and operational presence across various regions.
